LC16m8 vaccine (Q95615): Difference between revisions
From determinar.ia.br - Determine suas informações
Created a new Item |
Changed label, description and/or aliases in pt-br, en |
||
| description / pt-br | description / pt-br | ||
Vacina Mpox na Lista de Uso Emergencial da OMS desde agosto de 2024._x000D_ LC16 (KMB)” (vacina LC16m8) está indicada para imunização ativa para prevenir a doença mpox e a_x000D_ vacina é administrada por imunização por punção múltipla usando agulha bifurcada. É administrada como uma vacina de dose única a partir de um ano de idade. | |||
| description / en | description / en | ||
Mpox vaccine with WHO Emergency Use Listing since August 2024. LC16 (KMB)” (LC16m8 vaccine) is indicated for active immunization to prevent mpox disease and the vaccine is given by multiple puncture vaccination using bifurcated needle. It is given as a one dose vaccine from one year of age. | |||
Revision as of 11:25, 16 August 2026
Mpox vaccine with WHO Emergency Use Listing since August 2024. LC16 (KMB)” (LC16m8 vaccine) is indicated for active immunization to prevent mpox disease and the vaccine is given by multiple puncture vaccination using bifurcated needle. It is given as a one dose vaccine from one year of age.
| Language | Label | Description | Also known as |
|---|---|---|---|
| default for all languages | ID_428806626 |
||
| English | LC16m8 vaccine |
Mpox vaccine with WHO Emergency Use Listing since August 2024. LC16 (KMB)” (LC16m8 vaccine) is indicated for active immunization to prevent mpox disease and the vaccine is given by multiple puncture vaccination using bifurcated needle. It is given as a one dose vaccine from one year of age. |
